Neogen (NEOG) EBIT Margin (2010 - 2026)
Neogen's quarterly EBIT Margin came in at 1.56% in Q1 2026, down 401.0% year-on-year from 0.52% in Q1 2025, and up 34.71% quarter-over-quarter from 2.39% in Q4 2025.
Neogen has reported EBIT Margin for 17 years, with the latest figure at 1.56% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 401.0% year-over-year to 1.56%; the trailing twelve-month figure through Feb 2026 stood at 21.5% (up 7651.0% YoY), and the FY2025 full-year result was 26.59%, down 2627.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 1.56%, up from 2.39% in the prior quarter.
- The five-year high for EBIT Margin was 93.98% in Q2 2025, with the low at 197.82% in Q4 2024.
- Average EBIT Margin over 5 years is 4.51%, with a median of 4.58% recorded in 2022.
- Year-over-year, EBIT Margin slumped 20412 bps in 2024 and jumped 19543 bps in 2025.
- Tracing NEOG's EBIT Margin over 5 years: stood at 3.33% in 2022, then surged by 289 bps to 6.3% in 2023, then slumped by 3240 bps to 197.82% in 2024, then surged by 99 bps to 2.39% in 2025, then soared by 35 bps to 1.56% in 2026.
- The last three EBIT Margin figures came in at 1.56% (Q1 2026), 2.39% (Q4 2025), and 7.69% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | -1.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.56% |
| Nov 30, 2025 | -2.39% |
| Aug 31, 2025 | -7.69% |
| May 31, 2025 | 93.98% |
| Feb 28, 2025 | 2.44% |
| Nov 30, 2024 | -197.82% |
| Aug 31, 2024 | 1.04% |
| May 31, 2024 | -20.54% |
| Feb 29, 2024 | 5.25% |
| Nov 30, 2023 | 6.30% |
| Aug 31, 2023 | 8.36% |
| May 31, 2023 | 9.69% |
| Feb 28, 2023 | 7.19% |
| Nov 30, 2022 | -3.33% |
| Aug 31, 2022 | 4.58% |
| May 31, 2022 | 12.87% |
| Feb 28, 2022 | 4.97% |
| Nov 30, 2021 | 9.55% |
| Aug 31, 2021 | 16.95% |
| May 31, 2021 | 15.90% |
| Feb 28, 2021 | 13.52% |
| Nov 30, 2020 | 16.73% |
| Aug 31, 2020 | -1.79% |
| May 31, 2020 | 18.28% |
| Feb 29, 2020 | 13.06% |
| Nov 30, 2019 | 16.95% |
| Aug 31, 2019 | 16.04% |
| May 31, 2019 | 17.06% |
| Feb 28, 2019 | 14.98% |
| Nov 30, 2018 | 17.04% |
| Aug 31, 2018 | 16.54% |
| May 31, 2018 | 18.37% |
| Feb 28, 2018 | 16.77% |
| Nov 30, 2017 | 17.87% |
| Aug 31, 2017 | 17.43% |
| May 31, 2017 | 19.22% |
| Feb 28, 2017 | 16.24% |
| Nov 30, 2016 | 21.90% |
| Aug 31, 2016 | 129.32% |
| May 31, 2016 | -23.68% |
| Feb 29, 2016 | 14.67% |
| Nov 30, 2015 | 18.35% |
| Aug 31, 2015 | 19.90% |
| May 31, 2015 | -25.78% |
| Feb 28, 2015 | 17.78% |
| Nov 30, 2014 | 18.84% |
| Aug 31, 2014 | 19.88% |
| May 31, 2014 | 16.34% |
| Feb 28, 2014 | 16.60% |
| Nov 30, 2013 | 16.26% |
| Aug 31, 2013 | 21.21% |
| May 31, 2013 | 18.28% |
| Feb 28, 2013 | 18.93% |
| Nov 30, 2012 | 20.65% |
| Aug 31, 2012 | 20.77% |
| May 31, 2012 | 17.91% |
| Feb 29, 2012 | 16.81% |
| Nov 30, 2011 | 18.14% |
| Aug 31, 2011 | 20.46% |
| May 31, 2011 | -34.39% |
| Feb 28, 2011 | 19.10% |
| Nov 30, 2010 | 21.92% |
| Aug 31, 2010 | 22.36% |